ESC2025 Premium Access

Heart rate and cardiovascular outcomes with and without beta-blocker in post-mi patients: a pre-specified analysis of the ABYSS trial.

Congress Presentation

About the speaker

Associate Professor Michel Zeitouni

Pitie Salpetriere APHP University Hospital, Paris (France)
0 follower

5 more presentations in this session

Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)

Speaker: Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)

Thumbnail

PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study

Speaker: Doctor J. Ren (Tianjin, CN)

Thumbnail

Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis

Speaker: Mr V. Oliveira (Goiania, BR)

Thumbnail

Early PCSK9 inhibitor subscription during episode of acute myocardial infarction (EPISODE-AMI) study

Speaker: Professor C. Su (Taichung, TW)

Thumbnail

Long-term outcomes of prasugrel-based de-escalation versus conventional therapy after PCI in ACS patients

Speaker: Mr J. Yun (Seoul, KR)

Thumbnail

Access the full session

Novel pharmacological approaches in acute coronary syndromes

Speakers: Associate Professor M. Zeitouni, Professor I. Spyridopoulos, Doctor J. Ren, Mr V. Oliveira, Professor C. Su...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations